Patent · US Active

Combinatorial single molecule analysis of chromatin

US11479805B2 · kind B2 · utility

0Cited by
0References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 19, 2016
Grant dateOct 25, 2022
Priority date
Expiry dateOct 7, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/6878
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides for single-molecule profiling of combinatorial protein modifications and single-molecule profiling of combinatorial protein modifications combined with single-molecule sequencing of protein/nucleic acids complexes. High-throughput single-molecule imaging was applied to decode combinatorial modifications on millions of individual nucleosomes from pluripotent stem cells and lineage-committed cells. Applicants identified bivalent nucleosomes with concomitant repressive and activating marks, as well as other combinatorial modification states whose prevalence varies with developmental potency. Applying genetic and chemical perturbations of chromatin enzymes show a preferential affect on nucleosomes harboring specific modification states. The present invention also combines this proteomic platform with single-molecule DNA sequencing technology to simultaneously determine the modification states and genomic positions of individual nucleosomes. This novel single-molecule technology can be used to address fundamental questions in chromatin biology and epigenetic regulation leading to novel therapeutics and diagnostics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.